CA Stock MarketDetailed Quotes
PREV PreveCeutical Medical Inc
- 0.020
- 0.0000.00%
15min DelayMarket Closed Nov 22 14:12 ET
10.80MMarket Cap-10000P/E (TTM)
0.020High0.020Low50.75KVolume0.020Open0.020Pre Close1.02KTurnover0.03052wk High0.01%Turnover Ratio539.90MShares0.01552wk Low-0.002EPS TTM8.83MFloat Cap0.084Historical HighLossP/E (Static)441.70MShs Float-0.106Historical Low-0.002EPS LYR0.00%Amplitude--Dividend TTM-1.67P/B1Lot Size--Div YieldTTM
PreveCeutical Medical Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -64.49%-190.6K | 38.80%-58.42K | -33.39%-296.97K | -116.29%-37.18K | -3.99%-48.47K | 28.14%-115.87K | 60.72%-95.46K | 47.78%-222.64K | 172,987.12%228.21K | -120.10%-46.61K |
| Net income from continuing operations | -56.98%-361.96K | 38.25%-235.4K | 13.97%-1.27M | -226.71%-423.07K | 69.95%-239.64K | 44.65%-230.58K | 36.58%-381.19K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.09%-789 | --0 | --0 |
| Depreciation and amortization | 1.65%2.52K | 0.40%2.5K | -0.35%9.86K | -62.73%2.45K | 124.31%2.44K | 124.52%2.48K | 121.05%2.49K | 94.28%9.89K | 836.47%6.57K | -20.15%1.09K |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --38.82K | ---- | ---- |
| Remuneration paid in stock | --0 | --0 | -60.66%131.45K | 727.21%42.3K | -99.08%2.83K | -55.20%8.96K | 512.97%77.36K | 270.96%334.11K | -124.11%-6.74K | 2,562.01%308.23K |
| Other non cashItems | 3.50%79.22K | 7.16%79.06K | -19.07%308.99K | 127.95%79.34K | -73.35%79.34K | -9.34%76.54K | -73.98%73.78K | -41.52%381.81K | -269.20%-283.9K | 268.52%297.71K |
| Change In working capital | 235.27%89.62K | -27.76%95.42K | 6.53%527.21K | 87.57%261.81K | -25.96%106.57K | -82.16%26.73K | 114.70%132.09K | -16.52%494.89K | -52.04%139.58K | 6.44%143.94K |
| -Change in receivables | -1,868.55%-9.39K | -101.69%-232 | 657.16%13.11K | -172.30%-2.3K | 337.12%1.17K | 109.21%531 | 1,788.02%13.71K | -106.59%-2.35K | 34.68%3.18K | 93.23%-493 |
| -Change in prepaid assets | 147.28%17.07K | -178.26%-6.37K | 31.48%-18.47K | 249.47%32.55K | -65.78%-23.05K | -337.98%-36.11K | 226.02%8.14K | -370.15%-26.96K | -425.86%-21.77K | -238.07%-13.9K |
| -Change in payables and accrued expense | 31.51%81.94K | -7.47%102.02K | 1.60%532.57K | 46.39%231.56K | -18.87%128.45K | -55.63%62.31K | 63.93%110.25K | -4.19%524.2K | -43.91%158.17K | 19.54%158.33K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -64.49%-190.6K | 38.80%-58.42K | -33.39%-296.97K | -116.29%-37.18K | -3.99%-48.47K | 28.14%-115.87K | 60.72%-95.46K | 47.78%-222.64K | 174,306.87%228.21K | -120.10%-46.61K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -105.18%-170 | 76.26%-779 | 0 | 0 | 0 | 3.28K | -486.12%-3.28K | 101.61%850 | 0 | 0 |
| Net PPE purchase and sale | ---170 | ---779 | --0 | --0 | --0 | --0 | --0 | -66.00%850 | --0 | --0 |
| Net intangibles purchas and sale | ---- | --0 | ---- | ---- | ---- | ---- | ---3.28K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -105.18%-170 | 76.26%-779 | --0 | --0 | --0 | --3.28K | -486.12%-3.28K | 101.61%850 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 75.74%189.79K | -39.47%60.44K | 38.69%293.62K | -61.28%37.2K | 15.43%48.59K | 55,854.40%107.99K | 36.08%99.85K | 54.82%211.72K | 3,101.87%96.06K | 180.62%42.09K |
| Net issuance payments of debt | -22.23%83.99K | -39.47%60.44K | 34.56%293.62K | -61.28%37.2K | 15.43%48.59K | 155.60%107.99K | 164.10%99.85K | 59.57%218.21K | 3,101.87%96.06K | 180.62%42.09K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.49K | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 75.74%189.79K | -39.47%60.44K | 38.69%293.62K | -61.28%37.2K | 15.43%48.59K | 55,854.40%107.99K | 36.08%99.85K | 54.82%211.72K | 3,101.87%96.06K | 180.62%42.09K |
| Net cash flow | ||||||||||
| Beginning cash position | -53.76%2.81K | -74.54%1.43K | -64.99%5.62K | -31.11%1.68K | -4.81%2.51K | 83.49%6.08K | -64.99%5.62K | -89.73%16.06K | -98.27%2.44K | 102.62%2.64K |
| Current changes in cash | 78.73%-978 | 12.27%1.24K | 66.76%-3.35K | -99.99%18 | 102.68%121 | 97.15%-4.6K | 100.66%1.11K | 97.06%-10.08K | 791.19%324.27K | -101.83%-4.51K |
| Effect of exchange rate changes | -255.39%-1.6K | 120.67%135 | -131.96%-842 | 99.92%-269 | -121.98%-949 | -99.36%1.03K | -100.42%-653 | -100.18%-363 | -312.20%-321.09K | 179.84%4.32K |
| End cash Position | -90.68%234 | -53.76%2.81K | -74.54%1.43K | -74.54%1.43K | -31.11%1.68K | -4.81%2.51K | 83.49%6.08K | -64.99%5.62K | -64.99%5.62K | -98.27%2.44K |
| Free cash from | -69.44%-190.77K | 40.05%-59.2K | -33.39%-296.97K | -116.29%-37.18K | -3.99%-48.47K | 30.18%-112.59K | 59.37%-98.74K | 53.77%-222.64K | 535.40%228.21K | -120.10%-46.61K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data